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Abstract
Aim: To study impact of  once weekly iron supplementation 
on praziquantel cure rate, Schistosoma haematobium reinfection, 
and haematological parameters in pupils aged between 9 and 
15 years of  age in Nchelenge district, Zambia.
Methods: Pupils in the intervention group received once 
weekly dose of  ferrous sulphate at 200mg while those in 
the control received once weekly vitamin C at 100mg for up 
to 9 months. Both study groups received a single dose of  
praziquantel at baseline.
Results: S haematobium reinfection intensity was signiﬁcantly 
lower in boys in the intervention group than in boys in 
the control group at 6 months (P<0.001) and 9 months 
(P<0.001) of  supplementation. Signiﬁcantly lower S 
haematobium reinfection intensity was found in girls in the 
intervention group than in girls in the control group only 
at 6 months of  supplementation (P=0.018).  Boys in the 
intervention group were 42% (Adjusted Risk Ratio =0.58, 
95% conﬁdence interval 0.39, 0.86) less likely to be reinfected 
with S haematobium than in the control group at 6 months 
follow up. 
Conclusion: Once weekly iron supplementation can decrease 
S haematobium reinfection after 6 months and should be 
incorporated into school based schistosomiasis control 
programs in highly endemic areas.
Clinical trials.gov identiﬁer: NCT 00276224, sponsored 
by DBL-Institute for Health Research and Development, 
Denmark.
Introduction
Schistosomiasis and other parasitic infections contribute 
signiﬁcantly to the high prevalence of  iron deﬁciency 
anaemia in developing countries1-3. Other causes of  iron 
deﬁciency anaemia in tropical countries are dietary deﬁciency 
and impaired absorption4, 5. World Health Organisation 
(WHO) estimates the number of  anaemic people worldwide 
to be a staggering two billion and that approximately 50% 
of  all anaemia can be attributed to iron deﬁciency5. In areas 
endemic for schistosomiasis and other tropical diseases 
such as soil transmitted helminths infection (STH), iron 
deﬁciency anaemia accounts for about 50% of  the anaemia 
in schoolchildren and women2. The iron deﬁciency in 
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schistosomiasis and other tropical diseases such as STH is as 
a result of  blood loss that occurs in these infections. 
Chronic iron deﬁciency anaemia can lead to impaired 
immunity of  individuals infected with schistosomiasis and 
other tropical diseases6. It is widely believed that impaired 
host immunity as a result of  iron deﬁciency, increases the 
susceptibility of  infected individuals to reinfection with 
schistosomiasis and other tropical diseases7, 8. 
One method that could be used to correct and prevent the 
iron deﬁciency in areas endemic for schistosomiasis and other 
tropical diseases might be  iron supplementation of  infected 
and at risk individuals, respectively 1, 5, 9. Improved iron levels 
by iron supplementation in infected and at risk individuals 
might improve their immunity leading to increased resistance 
to reinfection with schistosomiasis and STH infections. 
In this article we present ﬁndings from a school-based trial 
of  placebo controlled once weekly iron supplementation 
entitled “Iron supplementation in schistosomiasis and soil 
transmitted helminths control programs in Zambia”. This 
trial compared once weekly iron supplementation with a 
placebo in terms of  the following endpoints; praziquantel 
cure rate of  S haematobium determined at 3 months post 
treatment, S haematobium reinfection intensities and rates at 6 
and 9 months post treatment, changes in mean haemoglobin 
levels and anaemia prevalence between baseline and after 
9 months of  iron supplementation, and mean number of  
doses of  iron/placebo received by each follow up times at 6 
and 9 months.
 
Materials and methods
Study design, area and population
 The study was a school-based placebo-controlled intervention 
trial conducted in Nchelenge district in Luapula province of  
Zambia. It was conducted between September 2005 and 
July 2006. The two schools, Kenani Upper Basic school and 
Chandwe Middle Basic School, were selected as the study 
schools for this trial. These two schools lie 3 kilometres 
apart, off  the shores of  Lake Mweru.  Kenani school was the 
intervention school where school children aged 9-15 years, 
of  either sex, in Grades 2,3, and 4, and present on the day 
of  screening formed the intervention group. These children 
received once weekly iron supplementation for a maximum 
nine months, interrupted by two one-month school holidays. 
Chandwe was the control school where children in Grades 
2 and 3, aged 9-15 years, of  either sex, and present on the 
day of  screening formed the control group that received 
a placebo (vitamin C) once weekly for a maximum nine 
months. This age group of  9-15 years was selected because 
it is ideal for the monitoring and evaluation of  school based 
schistosomiasis and STH infections control programs10. 
Vitamin C was only given to the control group and not to the 
intervention group so as to make the two groups comparable 
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in terms of  number of  tablets swallowed by the study pupils 
during the study period.
The only source of  S haematobium infected waters for 
both schools and the surrounding community is Lake 
Mweru. These two study schools were selected because the 
community in which they are situated is homogenous in 
terms of  the cultural, tribal and socio-economic status of  
households. The economic activities in this community are 
ﬁshing, trading, and subsistence farming. 
Sample size
The sample size was calculated using the Statcalc programme 
in Epi Info version 6.04c (Centres for Disease Control and 
Prevention, Atlanta, GA). A sample size of  240 children 
in each of  the study schools was calculated based on the 
study objectives of  comparing the effect of  weekly iron 
supplementation in children in both study schools using the 
following parameters (Conﬁdence Interval of  95%, Power 
of  80%, Unexposed: Exposed ratio of  1:1, Disease in the 
exposed of  20%, Risk ratio of  2.0, and Odds ratio of  2.25).
Baseline survey
Written informed consent was obtained from parents/
guardians before enrolment of  the study pupils. Pupils had 
also to give a verbal consent before being enrolled into the 
study and those who gave consent were then requested to 
submit one urine sample as well as blood drawn from their 
ﬁnger for haemoglobin analysis by the study nurse using a 
hemoglobinometer called Hemocue Hb 201+ (HemoCue 
AB, Angelholm, Sweden).
The study pupils were then asked to submit a second urine 
sample the following day. The urine samples were examined 
for S haematobium ova by the study laboratory technicians 
using the urine ﬁltration microscopy method (Vestergaard 
Frandsen A/S, Denmark). 
Treatment and iron supplementation
All the pupils participating in this study were given a single 
dose of  praziquantel regardless of  their infection status 
after submitting both urine samples and urine examination 
completed. The dosage for the praziquantel was calculated 
using the dose pole11. Once weekly iron supplementation in 
the intervention group and once weekly placebo (vitamin 
C) to all study pupils was provided on the day after 
administration of  praziquantel. The class teachers in the 
selected grades administered the once weekly iron/vitamin C 
supplementation for nine months under direct observation. 
The iron supplementation was given in form of  an oral 
tablet of  ferrous sulphate B.P of  200 mg (65 mg of  ferrous 
iron) once per week while vitamin C was given in form of  an 
oral tablet of  Ascorbic Acid B.P of  100 mg once per week, 
respectively.
Parasitological and haematological follow up
All the study pupils were followed up at three, six, and 
nine months post praziquantel treatment where they were 
requested to submit again two urine samples collected on 
two consecutive days. Methodology used here was exactly 
identical to that employed at baseline. The six and nine 
months sample points were used to assess effect of  duration 
of  iron supplementation on S haematobium reinfection. 
No additional praziquantel treatment was provided at either 
3 or 6 months follow-up.
End of  study treatment. All the study pupils were given 
a second dose of  praziquantel at the 9 months follow up 
regardless of  their S haematobium infection status. 
 
Statistics
Data were double entered in Epi Info v 6.04c. Data analysis 
was done in Epi Info, Stata version 6.0 (Stata Corp, College 
Station, TX), and SPSS. The statistical tests used in analysis 
were chi-square test for comparison of  proportions and t-test 
for comparison of  means. Primary outcome measures used to 
assess the impact of  once weekly iron supplementation were 
parasitological cure rate of  praziquantel for S haematobium 
infection at 3 months post treatment, S haematobium reinfection 
rate and intensity at 6 months, S haematobium reinfection rate 
and intensity at 9 months, and mean haemoglobin levels and 
anaemia prevalence at 9 months.  Parasitological cure rate of  
praziquantel for S haematobium infection was deﬁned as the 
proportion of  individuals who were diagnosed as negative 
from microscopic examination of  their urine. The measure 
used for the egg count for S haematobium infection for each 
individual was the maximum number of  eggs counted in any 
of  the two urine samples submitted at each of  the screening 
times and was recorded as egg/10 mL.  S haematobium 
reinfection at 6 months was deﬁned as the presence of  S 
haematobium ova in urine at 6 months in children who had 
been diagnosed as negative at three months and having had 
ova at baseline. S haematobium reinfection at 9 months was 
deﬁned as the presence of  S haematobium ova in urine at 9 
months in children who had been diagnosed as negative at 
3 months (regardless of  the S haematobium infection status 
at 6 months) and had ova at baseline. Anaemia was deﬁned 
according to WHO guidelines as haemoglobin levels less 
than 11 g/dL12. 
Geometric mean egg count was used to summarise the 
intensity of  S haematobium in intervention and control 
groups and it was calculated among all the children-positive 
and negative. Stratiﬁed analysis was conducted considering 
age as a possible confounder for each sex. An unadjusted 
estimates [Odds Ratio (OR), and Relative Risk (RR)] as well 
as adjusted estimates [Adjusted Odds Ratio (AOR), and 
Adjusted Relative Risk (ARR)] are presented together with 
their 95% Conﬁdence Interval (CI). 
Results
218 pupils in the intervention group and 228 pupils in the 
control group had complete available data for statistical 
analysis. 
The intervention and control groups were comparable 
in terms of  the sex distribution of  the study pupils.  The 
total number of  boys was 104 (47.7%) out of  218 pupils 
in the intervention group, and 111 (48.7%) out of  228 in 
the control group (p=0.836).  However, pupils in the control 
group tended to be younger than those in the intervention 
group (p<0.001), mean age in the control group being 10.5 
years (95% CI 10.2, 10.7) while that of  the intervention 
group was 11.1 years (95%CI 10.8, 11.3).  Overall 48 (22.0%) 
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of  pupils in the intervention group compared to 99 (43.4%) 
in the control group were below the age of  10 years.  
Infection rates of  S haematobium at baseline, 3 months, and 
at 9 months follow up were similar between the intervention 
and control groups among boys.  However, at 6 months 
follow-up, boys in the intervention group were 42% (ARR 
=0.58, 95%CI 0.39, 0.86) less likely to have had S haematobium 
reinfection compared to boys in the control group.  Among 
girls, infection rates of  S haematobium were similar between 
the two groups at baseline and at all follow up surveys. 
These results are shown in Table 1. When comparison was 
made between the study groups, without adjusting for age 
and sex, the S haematobium reinfection rates were signiﬁcantly 
higher in the control group compared to the intervention 
group at 6 months (P=0.032) and at 9 months (P=0.015 ) as 
demonstrated in Figure 1. 
Male Female
Follow-up Total   n (%) Crude risk estimate Adjusted risk 
estimate*
Total   n (%) Crude risk estimate Adjusted risk 
estimate*
OR (95%CI) AOR (95%CI) OR (95%CI) AOR (95%CI)
Baseline
Intervention 104   93(89.4) 0.40 (0.11, 1.32) 0.43 (0.14, 1.29) 114   103 (90.4) 0.60 (0.20, 1.76) 0.49 (0.18, 1.34)
Control 111   106 (95.5) 1 1 117   110 (94.0) 1 1
RR (95%CI) ARR (95%CI) RR (95%CI) ARR (95%CI)
3 months
Intervention 58     2 (3.4) 1.60 (0.23, 11.07) 1.44 (0.26, 7.88) 54     3 (5.6) 2.56 (0.44, 14.82) 4.13 (0.46, 36.67)
Control 93     2 (2.2) 1 1 92     2 (2.2) 1 1
6 months
Intervention 46    19 (41.3) 0.59 (0.41, 0.87) 0.58 (0.39, 0.86) 44     29 (65.9) 1.01 (0.77, 1.32) 0.79 (0.74, 1.26)
Control 72    50 (69.4) 1 1 72     47 (65.3) 1 1
9 months
Intervention 31    17 (54.8) 0.71 (0.51, 1.00) 0.73 (0.52, 1.03) 27     16 (59.3) 0.83 (0.58, 1.18) 0.79 (0.56, 1.12)
Control 74    57 (77.0) 1 1 63     45 (71.4) 1 1
 
 *  adjusted for age
Table 1:  Comparison of baseline, cure rate (3 months) and re-infection rates for S.haematobium at 6 and 9 months follow up between the 
intervention and control groups.
 Figure 1. S. haematobium  infection at baseline, post 
treatment residual infection at 3 months, and reinfection 
at 6 and 9 months
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Table 2 shows the distribution of  S haematobium intensity 
between the study groups for each sex at each survey. 
Intensities of  S haematobium infection were comparable 
between the intervention and control group at baseline and at 
subsequent follow up surveys apart from the 6 months follow 
up among girls.  At the 6 months follow up, the intensity 
of  S haematobium reinfection was heavier in the control 
group than in the intervention group among girls. Among 
boys, no signiﬁcant differences in S haematobium infection 
intensities were observed between the intervention and 
control group at baseline and at the 3 months follow up. 
At subsequent follow up surveys (6 and 9 months follow 
up), intensities of  infection were heavier among boys in 
the control group compared to the intervention group. 
Unadjusted comparison between the two study groups, 
showed that the intensities of  S haematobium reinfection 
were signiﬁcantly heavier in the control group compared 
to the intervention group at 6 months (P<0.01) and at 9 
months (P<0.01), as shown in Figure 2. 
The prevalence rates of  anaemia were comparable between 
the intervention and control group among boys at both the 
baseline, and at 9 months follow up.  At 9 months follow 
up, among girls, the control group had a signiﬁcantly 
higher prevalence of  anaemia than the intervention 
group; adjusted bivariate analysis for age showed that 
this association was no longer signiﬁcant (Table 3). At 9 
months follow up, unadjusted comparison between the 
two study groups, the prevalence of  anaemia was higher 
in the control group compared to the intervention group 
(P=0.014 ).
Mean haemoglobin (Hb) levels (Table 4) were not 
signiﬁcantly different between the intervention and 
control group at both baseline, and at 9 months follow 
up when adjusted analysis was performed. However, when 
unadjusted analyses were performed the mean haemoglobin 
levels were signiﬁcantly higher in the intervention group 
compared to the control group at 9 months follow up 
(P=0.014), as shown in Figure 3.
Unadjusted analyses also showed that mean number of  
doses of  iron/placebo supplementation received by 6 and 
9 months were not signiﬁcantly different between the two 
groups (P=0.278 and P=0.524, respectively), as shown in 
Table 2:  Comparison of S. haematobium infection intensity between 
the intervention and control group at each survey. 
Male Female
Follow-up Total Mean (SD) p 
value 
Total Mean
(SD)
p 
value 
Baseline
Intervention 104 1.699 (0.791) 0.164 114 1.647 
(0.752)
0.280
Control 111 1.842 (0.714) 117 1.754 
(0.744)
3 months
Intervention 58 0.050 (0.293) 0.612 54 0.052 
(0.216)
0.151
Control 93 0.029 (0.213) 92 0.014 
(0.098)
6 months
Intervention 46 0.407 (0.584) <0.001 44 0.652 
(0.633)
0.018
Control 72 1.028 (0.875) 72 1.025 
(0.907)
9 months
Intervention 31 0.552 (0.581) <0.001 27 0.826 
(0.793)
0.119
Figure 2. S. haematobium  intensity (geometric 
mean) of infection at baseline and 3 months and 
reinfection at 6 and 9 months follow ups
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Figure 4.
Discussion
There is still controversy over the beneﬁts of  iron 
supplementation in the control of  infections in endemic 
areas. Whereas certain studies have demonstrated positive 
impact of  iron supplementation on the control of  infections 
such as schistosomiasis13 and upper respiratory tract 
infections as well as diarrhoeal diseases14,15, other studies 
have found no beneﬁts of  iron supplementation on the 
control of  schistosomiasis and other helminths16 as well as 
malaria infections17, 18.
The two study schools are located in an area highly endemic 
for S haematobium infection as evidenced by the high prevalence 
at baseline (the prevalence of  S haematobium infection in the 
intervention group was 89.9% while that in the control 
group was 94.8%).  In our study, iron supplementation was 
administered by the school teachers. The mean number of  
doses of  iron supplementation received in the intervention 
group was comparable with that of  placebo in the control 
group at both 6 and 9 months follow up times.  This 
observation might imply that there were no signiﬁcant 
factors such as side effects to the intervention drug, iron, 
that could have made class attendance in the intervention 
group signiﬁcantly lower than in the control group through 
absenteeism. The high mean number of  doses of  the 
intervention and the placebo received by the study pupils 
at both follow up times indicated that school based iron 
supplementation programs could be feasible in areas highly 
endemic for S haematobium infection.
Once weekly iron supplementation had no impact on 
praziquantel cure rate for S haematobium infection determined 
at 3 months post treatment. This observation, it could be 
argued, was as expected as the period of  iron supplementation 
was too short for any effect to be seen on the immune 
system19. Furthermore, the high praziquantel cure rates for 
S haematobium observed in both study groups (96.6% for the 
intervention group and 97.8% for the control group) were 
acceptable considering the high prevalence of  S haematobium 
in the study area. 
The demonstration of  signiﬁcant reduction in the intensity 
and rate of  S haematobium reinfection after 6 months of  iron 
supplementation in the intervention group when compared 
Table 3:  Comparison of prevalence of anaemia between intervention and control group
Male Female
Follow-up Total     n (%) Crude risk estimate Adjusted risk 
estimate*
Total     n (%) Crude risk estimate Adjusted risk 
estimate*
OR (95%CI) AOR (95%CI) OR (95%CI) AOR (95%CI)
Baseline
Intervention 80         17 (21.3) 1.03 (0.46, 2.34) 1.04 (0.58, 1.89) 73        11 (15.1) 0.42 (0.17, 0.99) 0.50 (0.23, 1.13)
Control 87         18 (20.7) 1 1 84        25 (29.8) 1 1
RR (95%CI) ARR (95%CI) RR (95%CI) ARR (95%CI)
9 months
Intervention 80         3 (3.8) 0.36 (0.10, 1.29) 0.34 (0.08, 1.35) 73         3 (4.1) 0.31 (0.09, 1.08) 0.31 (0.09, 1.10)
Control 87         9 (10.3) 1 1 84        11 (13.1) 1 1
*  adjusted for age
Table 4:  Comparison of haemoglobin levels between the intervention and control group
Male Female
Follow-up Total Mean (SD) p value Total Mean (SD) p value 
Baseline
Intervention 80     11.79 (1.136) 0.793 73 11.86 (1.085) 0.215
Control 87 11.83 (1.280) 84 11.63 (1.241)
9 months
Intervention 80 12.98 (1.115) 0.104 73 13.02 (1.116) 0.067
Control 87 12.66 (1.331) 84 12.65 (1.354)
Change in Hb from baseline  to 9 months  follow up
Total Mean change 
(SD)
p value Total Mean change 
(SD)
p value 
Intervention 80 1.19 (1.268) 0.081 73 1.16 (1.343) 0.537
Control 87 0.83 (1.379) 84 1.02 (1.380)
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Figure 3. Mean haemoglobin levels at baseline and 9 
months follow up
10.5
11
11.5
12
12.5
13
13.5
Baseline 9 months
Time
H
b 
(g
/d
l)
Intervention group
Control group
 
Figure 4. Mean number of doses of iron/placebo 
received by each follow up time
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with the placebo group in our study implies that there 
was a positive impact of  iron on the host immune system 
towards new infection. It may be argued that increased iron 
supplementation might have enhanced the immune system in 
destroying new invading schistosomes and thereby reducing 
reinfection rate and intensity of  S haematobium20, 13. We do 
not think there were any confounding factors, for example 
nutritional status differences between the two study groups, 
that could explain this observation as the two study groups 
were comparable in terms of  geographical location of  the 
two schools, various diseases prevalence in the community, 
health care provision in the community, and the social and 
economic status of  the study pupils. The pupils in the two 
study groups belonged to one and same community.
Our study failed to demonstrate signiﬁcant increase in mean 
haemoglobin levels and reduction in anaemia prevalence 
after 9 months of  iron supplementation in the intervention 
group when compared with the control group. The probable 
explanation for this observation is that the period of  iron 
supplementation might have been too short for any signiﬁcant 
effect on haemoglobin levels and therefore anaemia. Further 
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research is therefore warranted to establish the impact of  
longer duration of  once weekly iron supplementation on 
haemoglobin levels and anaemia.
Even though iron supplementation was insufﬁcient in 
signiﬁcantly increasing haemoglobin levels and thereby not 
signiﬁcantly reducing anaemia, it was sufﬁcient in correcting 
the iron deﬁciency and thereby having a positive impact on S 
haematobium re-infection. The explanation for this observation 
is that the levels of  iron required to have a positive impact on 
S haematobium re-infection is lower than the levels required to 
signiﬁcantly increase the haemoglobin levels and therefore 
signiﬁcantly reduce the anaemia. The causation of  anaemia 
in our study children most likely was multifactorial, with 
iron deﬁciency being one of  them. Iron supplementation 
corrected the iron deﬁciency which was enough to increase 
resistance to S haematobium re-infection but not enough to 
correct the iron deﬁciency anaemia. No studies have been 
conducted before in our study children to establish the iron 
stores of  these children. 
In conclusion, this study has demonstrated that in an 
area highly endemic for S haematobium infection, school 
based once weekly iron supplementation in the control of  
schistosomiasis is feasible and can reduce S haematobium 
reinfection signiﬁcantly after 6 months of  supplementation. 
We recommend that once weekly iron supplementation 
should be incorporated into school based schistosomiasis 
control programs in highly endemic areas. 
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